Avid Bioservices Inc (CDMO)

[NoMoDo]

From the most recent 8k:

Avid’s current manufacturing revenue backlog is $68 million, representing estimated future manufacturing revenue to be recognized under committed contracts. This backlog covers revenue to be recognized in fiscal year 2017 and into fiscal year 2018.

By the wording here and other places, a third facility will be needed to get through the future already contracted orders.

It is realistic that dilution will be severely reduced even within the next 6 months. Within the next year, dilution could be a thing of the past.